The role of vaccines in preventing bacterial antimicrobial resistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of vaccines in preventing bacterial antimicrobial resistance
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 24, Issue 1, Pages 10-19
Publisher
Springer Nature
Online
2018-01-10
DOI
10.1038/nm.4465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries
- (2017) Robert Cohen et al. Expert Review of Vaccines
- Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
- (2017) Emma Rey-Jurado et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing
- (2017) Zhong Peng et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
- (2017) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail
- (2017) Debra A Goff et al. LANCET INFECTIOUS DISEASES
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
- (2017) Robert W. Frenck et al. VACCINE
- A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential
- (2017) Timothy F. Landers et al. PUBLIC HEALTH REPORTS
- Escherichia coli Harboringmcr-1andblaCTX-Mon a Novel IncF Plasmid: First Report ofmcr-1in the United States
- (2016) Patrick McGann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol
- (2016) Julia Simioni et al. BMC Pediatrics
- Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine
- (2016) Sara Tomczyk et al. CLINICAL INFECTIOUS DISEASES
- Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention
- (2016) Gustavo H. Dayan et al. Expert Review of Vaccines
- Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011
- (2016) Katherine E. Fleming-Dutra et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion
- (2016) Marian L. Gaviola et al. PHARMACOTHERAPY
- Siderophore vaccine conjugates protect against uropathogenicEscherichia coliurinary tract infection
- (2016) Laura A. Mike et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
- (2016) Geert Leroux-Roels et al. VACCINE
- A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults
- (2016) Eric Sheldon et al. VACCINE
- Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
- (2016) Germie P.J.M. van den Dobbelsteen et al. VACCINE
- Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers
- (2016) Nicole Bézay et al. VACCINE
- Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
- (2016) Guy de Bruyn et al. VACCINE
- How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
- (2016) Marc Lipsitch et al. mBio
- Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study
- (2016) Matthew R Moore et al. Lancet Respiratory Medicine
- One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A
- (2016) Francesca Mancini et al. PLoS One
- The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis
- (2015) John C. Kash et al. AMERICAN JOURNAL OF PATHOLOGY
- Extraintestinal PathogenicEscherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field
- (2015) Jan T. Poolman et al. JOURNAL OF INFECTIOUS DISEASES
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response
- (2015) Leire Aguinagalde et al. PLoS One
- Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status
- (2014) Gonçalo Matias et al. Influenza and Other Respiratory Viruses
- Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
- (2014) PEDIATRICS
- The contribution of vaccination to global health: past, present and future
- (2014) B. Greenwood PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
- (2014) Stefan H E Kaufmann et al. Lancet Respiratory Medicine
- Intrawound Vancomycin Powder Reduces Surgical Site Infections in Posterior Cervical Fusion
- (2013) Cyrus Caroom et al. SPINE
- Vaccines against gonorrhea: Current status and future challenges
- (2013) Ann E. Jerse et al. VACCINE
- Identification and characterization of antigens as vaccine candidates againstKlebsiella pneumoniae
- (2013) Urban Lundberg et al. Human Vaccines & Immunotherapeutics
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008
- (2012) Hong Zhou et al. CLINICAL INFECTIOUS DISEASES
- Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults
- (2012) Kyle Widmer et al. JOURNAL OF INFECTIOUS DISEASES
- Scaling up interventions to achieve global tuberculosis control: progress and new developments
- (2012) Mario Raviglione et al. LANCET
- Emergence and global spread of epidemic healthcare-associated Clostridium difficile
- (2012) Miao He et al. NATURE GENETICS
- Effect of a Best-Practice Alert on the Rate of Influenza Vaccination of Pregnant Women
- (2012) Timothy E. Klatt et al. OBSTETRICS AND GYNECOLOGY
- Adherence to Surgical Care Improvement Project Measures and Post-Operative Surgical Site Infections
- (2012) Samir S. Awad Surgical Infections
- Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae
- (2011) Thomas Tängdén et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines
- (2011) L. M. Hampton et al. JOURNAL OF INFECTIOUS DISEASES
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
- (2011) Timothy R Walsh et al. LANCET INFECTIOUS DISEASES
- Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine
- (2010) Charles F von Reyn et al. AIDS
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Invasive group B streptococcal disease in an orthopaedic unit
- (2010) P.J. Jenkins et al. JOURNAL OF HOSPITAL INFECTION
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
- (2010) Harish Nair et al. LANCET
- Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination
- (2010) H.J. Adam et al. VACCINE
- Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease
- (2010) Inci Yildirim et al. VACCINE
- Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
- (2009) D. Yong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Universal Influenza Immunization on Antibiotic Prescriptions: An Ecological Study
- (2009) Jeffrey C. Kwong et al. CLINICAL INFECTIOUS DISEASES
- Staphylococcal Vaccines and Immunotherapies
- (2009) Adam C. Schaffer et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Staphylococcus aureusantigens and challenges in vaccine development
- (2008) John R Middleton Expert Review of Vaccines
- Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals
- (2008) Ann R. Falsey et al. JOURNAL OF INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started